UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$498M |
| 2 |
Ametek
AME
|
+$445M |
| 3 |
Microsoft
MSFT
|
+$432M |
| 4 |
Apple
AAPL
|
+$209M |
| 5 |
Tesla
TSLA
|
+$198M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$759M |
| 2 |
Accenture
ACN
|
+$529M |
| 3 |
ConocoPhillips
COP
|
+$392M |
| 4 |
iShares Core S&P Total US Stock Market ETF
ITOT
|
+$324M |
| 5 |
iShares Core S&P Small-Cap ETF
IJR
|
+$310M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.01% |
| 2 | Healthcare | 15.34% |
| 3 | Financials | 12.73% |
| 4 | Consumer Discretionary | 9.85% |
| 5 | Industrials | 8.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2601
Matsons
MATX
$6.18B
| – | – |
-17,376
| Closed | -$1.07M |
|
2602
Malibu Boats
MBUU
$567M
| – | – |
-22,144
| Closed | -$1.06M |
|
2603
Moelis & Co
MC
$4.94B
| – | – |
-65,686
| Closed | -$2.22M |
|
|
MCW
2604
DELISTED
Mister Car Wash
MCW
| – | – |
-80,194
| Closed | -$688K |
|
2605
Pediatrix Medical
MD
$2.2B
| – | – |
-88,573
| Closed | -$1.46M |
|
2606
Madrigal Pharmaceuticals
MDGL
$11.8B
| – | – |
-16,634
| Closed | -$1.08M |
|
2607
MiMedx Group
MDXG
$633M
| – | – |
-54,831
| Closed | -$157K |
|
2608
Medifast
MED
$141M
| – | – |
-10,845
| Closed | -$1.18M |
|
2609
Medpace
MEDP
$16.5B
| – | – |
-122,175
| Closed | -$19.2M |
|
2610
Methode Electronics
MEI
$592M
| – | – |
-50,748
| Closed | -$1.89M |
|
2611
Mercer International
MERC
$39.8M
| – | – |
-50,254
| Closed | -$618K |
|
2612
Ramaco Resources Class A
METC
$649M
| – | – |
-12,104
| Closed | -$108K |
|
|
MFA
2613
MFA Financial
MFA
$933M
| – | – |
-124,997
| Closed | -$972K |
|
2614
MGE Energy Inc
MGEE
$3.08B
| – | – |
-57,472
| Closed | -$3.77M |
|
2615
MacroGenics
MGNX
$257M
| – | – |
-30,117
| Closed | -$104K |
|
2616
MGP Ingredients
MGPI
$375M
| – | – |
-11,031
| Closed | -$1.17M |
|
2617
McGrath RentCorp
MGRC
$2.92B
| – | – |
-32,373
| Closed | -$2.71M |
|
2618
M/I Homes
MHO
$3.84B
| – | – |
-25,297
| Closed | -$917K |
|
2619
Marcus & Millichap
MMI
$1.19B
| – | – |
-27,610
| Closed | -$905K |
|
2620
Maximus
MMS
$3.1B
| – | – |
-67,044
| Closed | -$3.88M |
|
2621
Merit Medical Systems
MMSI
$5.32B
| – | – |
-59,196
| Closed | -$3.35M |
|
2622
MakeMyTrip
MMYT
$5.64B
| – | – |
-38
| Closed | -$1.17K |
|
2623
MannKind Corp
MNKD
$1.32B
| – | – |
-250,793
| Closed | -$775K |
|
2624
MP Materials
MP
$9.1B
| – | – |
-117,167
| Closed | -$3.2M |
|
2625
Maravai LifeSciences
MRVI
$919M
| – | – |
-2,152,901
| Closed | -$55M |
|
Similar funds
UBS AM's Q4 2022 Portfolio in Review
As of Q4 2022, UBS AM held 2,824 positions worth $191B, up 7% from $178B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
UBS AM's Q4 2022 filing shows 88 new, 1,334 increased, 722 reduced and 301 closed positions. Its largest new stake was Ferguson: 543,379 shares worth $69M. The largest sale was Amgen, an estimated $759M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 26% a quarter earlier, followed by Healthcare and Financials.
- UBS AM's largest Q4 2022 buy was Ferguson: 543,379 shares worth $69M.
- UBS AM added most to Amazon in Q4 2022, an estimated $498M increase.
- UBS AM's biggest Q4 2022 reduction was Accenture, cutting an estimated $529M.
- UBS AM fully exited Amgen in Q4 2022, selling an estimated $759M.
- UBS AM's ten largest holdings make up 19% of its $191B portfolio in Q4 2022.
- UBS AM opened 88 new positions and closed 301 in Q4 2022.
- UBS AM's portfolio value rose 7% quarter-over-quarter to $191B.
Based on UBS AM's 13F filing for Q4 2022, filed 14 Feb 2023.